Bilateral tibial marrow ablation in rats induces a rapid hypercalcemia arising from extratibial bone resorption inhibitable by methylprednisolone or deflazacort

Journal of Bone and Mineral Research

Volumn 12, Issue 2, 1997, Pages 200-209

  Magnuson, Scott K ^a,b   Booth, Randal ^a,b   Porter, Susan ^a,b   Gorski, Jeffrey P ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b ST LUKE S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; DEFLAZACORT; METHYLPREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; COLLAGEN SYNTHESIS; CONTROLLED STUDY; GLOMERULUS FILTRATION; HYPERCALCEMIA; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; RAT; TIBIA;

ALPHA-MACROGLOBULINS; ANIMALS; BONE MARROW; BONE RESORPTION; CALCIUM; DISEASE MODELS, ANIMAL; FRACTURE HEALING; HYDROXYPROLINE; HYPERCALCEMIA; MALE; METHYLPREDNISOLONE; PREGNENEDIONES; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 0031017902     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.2.200     Document Type: Article

References (50)

1. Gazit D, Shteyer A, Bab I 1989 Further characterization of osteogenic-cell growth promoting activity derived from healing bone marrow. Connect Tissue Res 23:153-161.
2. Schwartz Z, Sela J, Ramirez V, Amir D, Boyan, BD 1989 Changes in extracellular matrix vesicles during healing of rat tibial bone: A morphometric and biochemical study. Bone 10: 53-60.
3. Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, Bab I, Rodan GA 1993 Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 8:379-388.
4. Gazit D, Karmish M, Holzman L, Bab I 1990 Regenerating marrow induces systemic increase in osteo-and chondrogenesis. Endocrinology 126:2607-2613.
5. Liang CT, Barnes J, Seedor JG, Quartuccio HA, Bolander M, Jeffrey JJ, Rodan GA 1992 Impaired bone activity in aged rats: Alterations at the cellular and molecular levels. Bone 13: 435-441.
6. Tanaka H, Quarto R, Williams S, Barnes J, Liang CT 1994 In vivo and in vitro effects of insulin-like growth factor-1 (IGF-1) on femoral mRNA expression in old rats. Bone 15:647-653.
7. Cousins MJ, Bridenbaugh PO 1988 Neural blockade in clinical anesthesia and management of pain, 2nd Ed. JP Lippincott Co., Philadelphia, PA, U.S.A., pp. 946-950.
8. Hellewell AB, Beijan JR, Goldman M 1974 Effect of chronic administration of a glucocorticoid (prednisolone) on the rate of healing of experimental osseous defects. Clin Orthop 100:349-355.
9. Hogevold HE, Grogaard B, Reikeras O 1992 Effects of short-term treatment with corticosteroids and indomethacin on bone healing. Acta Orthop Scand 63:607-611.
10. Jett S, Wu K, Duncan H, Frost HM 1970 Adrenalcorticorsteroid and salicylate actions on human and canine haversian bone formation and resorption. Clin Orthop 68:301-315.
11. Jee WSS, Park HA, Roberts WE, Kenner GH 1970 Corticosteriod and bone. Am J Anat 129:477-479.
12. Hardy JR, Conlan D, Hay S, Gregg PJ 1993 Serum ionised calcium and its relationship to parathyroid hormone after tibial fracture. J Bone Joint Surg Br 75:645-649.
13. 3. Clin Orthop Rel Res 181:264-268.
14. Blunt JW, Plotz CM, Lattes R, Howes EL, Meyer K, Ragan C 1950 Effect of cortisone on experimental fractures in the rabbit. Proc Soc Exp Biol 73:678-681.
15. Jirarattanaphochai K, Kiat ST, Chua D, Song IC 1993 The effect of methylprednisolone on porcine bone morphogenetic protein in fracture healing. Clin Orthop Rel Res 292:366-375.
16. Dempster DW, Arlot MA, Meunier PJ 1983 Mean wall thickness and formation periods of trabecular bone packets in corticosteriod-induced osteoporosis. Calcif Tissue Int 35:410-417.
17. Hahn TD 1981 Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocr Metab 52:111-115.
18. Reid IR, Ibberston HK 1987 Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Hormone Res 27:200-204.
19. Suzuki Y, Ichikawa Y, Saito E, Homma M 1983 Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151-156.
20. Messina OD, Barreira JC, Zanchetta JR, Maldonado-Cocco JA, Bogado CE, Sebastian ON, Flores D, Riopedre AM, Redondo G, Lazaro A 1992 Effect of low doses of deflazacort vs. prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol 19:1520-1526.
21. Caniggia A, Nuti R, Lore F, Vattimo A 1981 Pathophysiology of the adverse effects of glucoactive cortiocosteriods on calcium metabolism in man. J Steriod Biochem 15:153-161.
22. Kivirkko KI, Laitinen O, Prockop DJ 1967 Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19: 249-255.
23. 2-macroglobulin levels using an electroimmunoassay. Agents Actions 11:482-489.
24. Wecke B 1973 Rocket immunoelectrophoresis. Scand J Immunol 2(Suppl):37-46.
25. Glenn EM, Bowman BJ, Koslowske TC 1968 The systemic response to inflammation. Biochem Pharmacol March (Suppl): 27-49.
26. Gorski JP, Bronk JT, Moyer TP 1987 Mineralization of healing canine tibial defects. In: Sen A and Thornhill T (eds.) Development and Diseases of Cartilage and Bone Matrix. Alan R. Liss, Inc., New York, NY, U.S.A., pp. 377-387.
27. Schwartz A, Braun G, Kohavi D, Brooks B, Amir D, Sela J, Boyan B 1993 Effects of hydroxyapatite implants on primary mineralization during rat tibial healing: Biochemical and morphometric analyses. J Biomed Mater Res 27:1029-1038.
28. Meller Y, Kestenbaum RS, Mozes M, Mozes G, Yagil R, Shany S 1984 Mineral and endocrine metabolism during fracture healing in dogs. Clin Orthop 187:289-295.
29. Meller Y, Shainkin-Kestenbaum R, Shany S, Zuilli I, Yankowitz, N, Giat J, Konforti A, Torok G 1984 Parathyroid hormone, calcitonin, and vitamin D metabolites during normal fracture healing in humans: A preliminary report. Clin Orthop 183: 238-245.
30. Cooper C, Mclaren M, Wood PJ, Coulton L, Kanis JA 1989 Indices of calcium metabolism in women with hip fractures. Bone Miner 5:193-200.
31. Lal SK, Jacob KC, Nagi ON, Annamalai AL, Nair CR 1976 Variations of some plasma components after closed fractures. J Trauma 16:206-211.
32. Bagnoli F, Bruchi, S Sardelli S, Vispi L, Buonocore G, Franchi F1984 Calcitonin and parathyroid hormone in newborn infants with fracture of the clavicle. Calcif Tissue Int 36:357-360.
33. Mallmin H, Ljunghall S, Larsson K 1993 Biochemical markers of bone metabolism in patients with fracture of the distal forearm. Clin Orthop 295:259-263.
34. Markham A, Bryson HM 1995 Deflazacort: A review of its pharmacological properties and therapeutic efficacy. Drugs 50:317-333.
35. Mollmann H, Hochhaus G, Rohatagi S, Barth J, Derendorf H 1995 Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methyprednisolone and prednisone. Pharm Res 12:1096-1100.
36. van der Veen MJ, Bijlsma JW 1992 Effects of different regimes of corticosteriod treatment on calcium and bone metabolism in rheumatoid arthritis. Clin Rheumatol 11:388-392.
37. Girasole G, Passeri G, Jilka RL, Manologas SC 1994 Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524.
38. Passeri G, Girasole G, Manolagas SC, Jilka RL 1994 Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: Influence on IL-6 production and osteoclast development. Bone Miner 24:109-126.
39. Girasole G, Jilka RL, Passed G, Boswell S, Boder G, Williams DC, Manolagas SC 1992 17-β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effects of estrogens. J Clin Invest 89:883-891.
40. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R 1995 Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136: 3054-3061.
41. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P 1991 Interleukin-1/3 stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10:15-21.
42. Yoneda T, Alsina MA, Chavez JB, Bonewald L, Nishimura R, Mundy GR 1991 Evidence that tumor necrosis factor plays a hormonal role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. J Clin Invest 87:977-985.
43. Cipolle MD, Pasquale MD, Shearer J, Caldwell M, Cerra F 1994 Blunt injury augments interleukin-6 but not tumor necrosis factor in isolated, perfused rat hindlimbs. J Trauma 37:91-98.
44. Wiktor Jedrzejczak W 1993 In vivo role of macrophage growth factors as delineated using CSF-1 deficient op/op mouse. Leukemia 7(Suppl 2):S117-S121.
45. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N 1995 Modulation of osteoclast differentiation by local factors. Bone 17(Suppl 2):87S-91S.
46. Emery P, Luqmani R 1993 The validity of surrogate markers in rheumatic disease. Br J Rheumatol 32(Suppl 3):3-8.
47. 2-acute phase globulin. Agents Actions 22:280-287.
48. Fletcher S, Thomas T, Schreiber G, Heinrich PC, Yeoh GC 1988 The development of rat alpha 2-macroglobulin: Studies in vivo and in cultured fetal rat hepatocytes. Eur J Biochem 171:703-709.
49. Baffet G, Braciak TA, Fletcher RG, Gauldie J, Fey GH, Northemann W 1991 Autocrine activity of interleukin 6 secreted by hepatocarcinoma cell lines. Mol Biol Med 8:141-156.
50. Schobitz B, Van Den Dobbelsteen M, Holsboer F, Sutanto W, De Kloet ER 1993 Regulation of interleukin 6 gene expression in rat. Endocrinology 132:1569-1576.